| Genomic Medicine |
1 |
1 |
| Genetics |
0 |
0.74 |
| Genetic Testing |
0 |
0.99 |
| Food and Drug Administration (FDA) |
0 |
0.37 |
| Child |
0 |
0.96 |
| Child and Adolescent Psychiatry |
0 |
0.98 |
| Adverse Effects |
0 |
0.26 |
| Patient Safety |
0 |
0.25 |
| Toxicology |
0 |
0.22 |
| Adolescent Medicine |
0 |
0.97 |
| Treatment Guidelines |
0 |
0.11 |
| California |
0 |
0.1 |
| Clinical Guidelines |
0 |
0.1 |
| Pharmacogenomics |
0 |
0.1 |
| Plasma |
0 |
0.1 |
| Depression |
0 |
0.09 |
| ADHD |
0 |
0.05 |
| Anxiety |
0 |
0.05 |
| Anxiety Disorder |
0 |
0.05 |
| Biomarker |
0 |
0.05 |
| Blood |
0 |
0.05 |
| Board Certification |
0 |
0.05 |
| Brain |
0 |
0.05 |
| Hand |
0 |
0.05 |
| Medical Literature |
0 |
0.05 |
| Metabolism |
0 |
0.05 |
| Nevada |
0 |
0.05 |
| Obsessive-Compulsive Disorder |
0 |
0.05 |
| Pharmacodynamics |
0 |
0.05 |
| Plague |
0 |
0.05 |
| Preventive Screening |
0 |
0.05 |
| Psychopharmacology |
0 |
0.05 |
| Stevens-Johnson Syndrome |
0 |
0.05 |
| Tropical Diseases |
0 |
0.05 |